Zydus Lifesciences

ZYDUSLIFE

₹ 982.15

₹ 13.95

1.44%

Zydus Lifesciences
Market Sentiment

Timeline	Returns	Volume
Daily	-	-
Weekly	-1.53%	73,65,999
Monthly	-1.21%	2,69,02,581

Zydus Lifesciences
Performance

DATA

CHART

Timeline	Daily	Weekly	Monthly
ZYDUSLIFE	-	-1.53%	-1.21%
Index	-	-1.46%	-2.67%
Peer Avg.	-	-3.07%	-0.54%

*Avg of index constituents

Zydus Lifesciences
Fundamentals

DATA

CHART

Timeline	PE	PB	EV/EBIDTA	ROE	ROCE	Div. Yield
ZYDUSLIFE	24.79	2.40	13.74	11.06	11.64	0.57
Index	36.20	6.77	17.25	17.89	19.69	1.20
Peer Avg.	40.04	4.96	12.35	14.74	18.51	0.87

*Avg of index constituents

Zydus Lifesciences
Key Metrics

DATA

CHART

Metrics	Sales Growth	Profit Growth	ROE	ROCE
FY '21-22	4.29%	-18.20%	11.06	11.64
FY '20-21	7.32%	46.05%	15.59	12.68
FY '19-20	6.44%	-20.71%	12.79	11.87

Zydus Lifesciences
Shareholding Pattern

Promoters : 74.88%

FII : 2.53%

DII : 12.91%

Public : 9.69%

Others : 0%

Zydus Lifesciences
Profit & Loss

DATA

CHART

Metrics	Sales	Expenditure	EBITDA	PAT
FY '21-22	11,623.55	9,000.35	2,831.10	1,592.15
FY '20-21	11,091.75	8,245.40	2,915.35	1,840.90
FY '19-20	10,551.40	8,417.25	2,619	1,294.25

All values are in crores

Zydus Lifesciences
Peer Comparison

DATA

CHART

Metrics	Sales	Expenditure	EBITDA	PAT
ZYDUSLIFE	11,623.55	9,000.35	2,831.10	1,592.15
ACC	0	0	0	0
PAGEIND	4,020.58	3,233.72	807.85	536.53

All values are in crores

Zydus Lifesciences
Similar Stocks

Glaxosmithkline Pharmaceuticals

GLAXO

₹ 1,972.30

- ₹ 3.60

-0.18%

Zydus Lifesciences Share Price

Zydus Lifesciences Ltd. is an Indian life sciences company. The Company is engaged in the research and development, manufacturing, marketing and sale of human medicines, such as generic medicines and specialty products, including biosimilars and vaccines; active pharmaceutical ingredients (API); animal health products and consumer protection products. Its products include Bilypsa (saroglitisar), Oxemia (desidustat), Ujvira (biologically similar to Kadcyla), and Exemptia. It offers Bilypsa for the treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Desidustat is an oral, small molecule, hypoxia-inducible factor-prolyl-hydroxylase (HIF-PH) inhibitor used to treat anemia in patients with chronic kidney disease (CKD). He is also developing an oral ZYIL1 small molecule to selectively suppress inflammation caused by the NLRP3 inflammasome. Its ZyCoV-D is a plasmid deoxyribonucleic acid (DNA) vaccine against COVID-19.

Zydus Lifesciences FAQs

How to Buy Zydus Lifesciences Share?

To purchase Zydus Lifesciences shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Zydus Lifesciences (ticker symbol: zyduslife) on the trading platform provided by your broker and purchase the shares.

What's Zydus Lifesciences share price today?

The stock price of Zydus Lifesciences as of 10 May 2024 is ₹982.15

What is the Market Cap of Zydus Lifesciences?

Market capitalisation represents the total market value of a company's outstanding shares. As of 10 May 2024, Zydus Lifesciences (ticker symbol: zyduslife) has a market capitalisation of approximately ₹4,46,63,50,76,333.75

What is the PE and PB ratio of Zydus Lifesciences?

Zydus Lifesciences Ltd's price-to-book ratio as of 10 May 2024 is 2.3986232, reflecting the market's valuation compared to its asset value. As of 10 May 2024, the trailing twelve months P/E (price-to-earnings) ratio is 24.789364, indicating the market values the company at around ₹24.79 for every ₹1 of earnings

What is the 52 Week High and Low of Zydus Lifesciences Share?

Zydus Lifesciences Ltd (zyduslife) hit its 52-week high at ₹1,033.00, and its 52-week low at { ₹484.95}.